KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Accounts Payables: 2019-2025

  • Aurora Cannabis' Accounts Payables rose 18.03% to $51.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $51.3 million, marking a year-over-year increase of 18.03%. This contributed to the annual value of $51.3 million for FY2025, which is 18.03% up from last year.
  • Aurora Cannabis' Accounts Payables amounted to $51.3 million in Q1 2025, which was up 18.03% from $43.5 million recorded in Q1 2024.
  • In the past 5 years, Aurora Cannabis' Accounts Payables ranged from a high of $54.8 million in Q2 2022 and a low of $43.5 million during Q1 2024.
  • For the 3-year period, Aurora Cannabis' Accounts Payables averaged around $49.2 million, with its median value being $51.3 million (2025).
  • Its Accounts Payables has fluctuated over the past 5 years, first dropped by 17.55% in 2024, then increased by 18.03% in 2025.
  • Quarterly analysis of 4 years shows Aurora Cannabis' Accounts Payables stood at $54.8 million in 2022, then reached $52.7 million in 2023, then declined by 17.55% to $43.5 million in 2024, then rose by 18.03% to $51.3 million in 2025.
  • Its Accounts Payables was $51.3 million in Q1 2025, compared to $43.5 million in Q1 2024 and $52.7 million in Q1 2023.